Caseware UK (AP4) 2023.0.135 2023.0.135 2024-02-292024-02-2912023-03-24falsetrueHolding company of intellectual property0truefalse 14755148 2023-03-23 14755148 2023-03-24 2024-02-29 14755148 2022-03-24 2023-03-23 14755148 2024-02-29 14755148 c:Director1 2023-03-24 2024-02-29 14755148 d:CopyrightsPatentsTrademarksServiceOperatingRights 2024-02-29 14755148 d:CurrentFinancialInstruments 2024-02-29 14755148 d:ShareCapital 2024-02-29 14755148 c:FRS102 2023-03-24 2024-02-29 14755148 c:Audited 2023-03-24 2024-02-29 14755148 c:FullAccounts 2023-03-24 2024-02-29 14755148 c:PrivateLimitedCompanyLtd 2023-03-24 2024-02-29 14755148 c:SmallCompaniesRegimeForAccounts 2023-03-24 2024-02-29 14755148 d:CopyrightsPatentsTrademarksServiceOperatingRights d:ExternallyAcquiredIntangibleAssets 2023-03-24 2024-02-29 14755148 d:CopyrightsPatentsTrademarksServiceOperatingRights d:OwnedIntangibleAssets 2023-03-24 2024-02-29 14755148 e:PoundSterling 2023-03-24 2024-02-29 iso4217:GBP xbrli:pure

Registered number: 14755148










MAVEN CLINIC LTD










FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 29 FEBRUARY 2024

 
MAVEN CLINIC LTD
REGISTERED NUMBER: 14755148

BALANCE SHEET
AS AT 29 FEBRUARY 2024

2024
Note
£

  

Current assets
  

Debtors: amounts falling due within one year
 5 
1

  
1

Total assets less current liabilities
  
 
 
1

  

Net assets
  
1


Capital and reserves
  

Called up share capital 
  
1

  
1


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 February 2025.




K Ryder
Director

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
MAVEN CLINIC LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 29 FEBRUARY 2024

1.


General information

Maven Clinic Ltd is a private company limited by shares, incorporated in England and Wales (registered number: 14755148) on 24 March 2023. Its registered office is 85 Great Portland Street, First Floor, London, England, W1W 7LT. The principal activity of the entity is to hold intellectual property.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.
Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

 
2.3

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 2

 
MAVEN CLINIC LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 29 FEBRUARY 2024

2.Accounting policies (continued)

 
2.4

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.
Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees

The average monthly number of employees, including directors, during the period was 1.

Page 3

 
MAVEN CLINIC LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 29 FEBRUARY 2024

4.


Intangible assets



Trademarks

£



Cost


Additions
1



At 29 February 2024

1



Amortisation


Charge for the period on owned assets
1



At 29 February 2024

1



Net book value



At 29 February 2024
-

During the period the company acquired trademarks from a fellow group company for £1. This has been fully amortised during the period. The consideration of £1 was held in an inter-group loan account which was written of during the period.




5.


Debtors

2024
£


Amounts owed by group undertakings
1



6.


Controlling party

The ultimate controlling party and immediate parent company is Maven Clinic Co. Its registered office is 160 Varick Street, 6th Floor, New York, United States NY10 013. Maven Clinic Co owns 100% of Maven Clinic Ltd.


7.


Auditors' information

The auditors' report on the financial statements for the period ended 29 February 2024 was unqualified.

The audit report was signed on 6 February 2025 by Howard Freeman (Senior Statutory Auditor) on behalf of Shorts.

 
Page 4